论文部分内容阅读
血管通路是血液透析患者的生命线,当尚未建立永久性血管通路或内瘘堵塞的患者需要进行透析时,临床上多采用先建立临时性中心静脉导管来保证其有效透析。透析时达不到充足的血流量,经调整导管位置无效或者抽吸导管失败,均提示导管内形成血栓,此时切实可行的办法就是用尿激酶进行溶栓处理。现就我院中心静脉插管患者10例进行尿激酶溶栓治疗,取得较好效果,报告如下。1资料与方法1.1临床资料中心静脉插管行血液透析患者10例,男6
Vascular access is the lifeblood of hemodialysis patients. When patients who have not established permanent vascular access or fistula occlusion need dialysis, they should first establish a temporary central venous catheter to ensure effective dialysis. Dialysis can not reach adequate blood flow, the catheter position is adjusted invalid or suction catheter failure, prompted the formation of thrombosis within the catheter, then a viable solution is to use urokinase thrombolytic treatment. Now on our hospital central venous catheterization in 10 cases of urokinase thrombolysis and achieved good results, the report is as follows. 1 Materials and Methods 1.1 Clinical data Central venous catheter hemodialysis patients 10 cases, 6 men